Dual‐targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual‐targeted therapy with apremilast and vedolizumab in pyoderma gangrenosum associated with Crohn’s disease

Published:2020-04-29 Issue:6 Volume:47 Page:
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Vernero Marta¹^ORCID,Ribaldone Davide Giuseppe²,Cariti Caterina³,Ribero Simone³,Susca Sara³,Astegiano Marco⁴,Dapavo Paolo³

Affiliation:

1. First Department of Internal Medicine University of Pavia Pavia Italy

2. Department of Medical Sciences University of Turin Turin Italy

3. Department of Medical Sciences Dermatologic Clinic University of Turin Turin Italy

4. Unit of Gastroenterology Molinette Hospital Turin Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1346-8138.15283

Reference5 articles.

1. Skin Manifestations of Inflammatory Bowel Disease

2. Pyoderma gangrenosum: a review of pathogenesis and treatment

3. Vedolizumab Treatment in Extra-Intestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review

4. Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria

5. Novel use of apremilast for adjunctive treatment of recalcitrant pyoderma gangrenosum

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of Pyoderma Gangrenosum;Dermatologic Clinics;2023-12

2. New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review;The Journal of Dermatology;2023-11-27

3. Breaking through the therapeutic ceiling of inflammatory bowel disease: Dual-targeted therapies;Biomedicine & Pharmacotherapy;2023-02

4. The recipe for the perfect inflammatory bowel disease nurse in a northern Italy tertiary IBD center: going beyond clinical care;Minerva Gastroenterology;2022-12

5. Multiple Lesions at Different Stages of Pyoderma Gangrenosum in a Crohn’s Disease Patient;Clinical, Cosmetic and Investigational Dermatology;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3